Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block

• Status: Completed
• Trial end date: 2021-06-29
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective, randomized, single blinded trial involving human subjects. The goal of this study is to determine an optimal location (proximal or distal) for the nerve block and whether it will make a difference in how much opioid the patient will receive during and after surgery. Ultrasound will identify the adductor canal and the proximal end of the adductor canal/apex of the femoral triangle to determine the location of the blocks.

Their will be two randomized groups: 1. ACB within true AC with bupivacaine 0.5% 20cc2. ACB proximal to true AC with bupivacaine 0.5% 20cc

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: New York University School of Medicine; NYU Langone Health
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Patients undergoing unilateral, ACL surgery with allograft.

• Patients who consent to be randomized.

• Patients must be English proficient.

Exclusion Criteria:

• Patients younger than 18 or older than 75 years of age;

• Patients with a history of chronic pain or who are taking medications intended to treat chronic pain such as strong opioids;

• Patients with history of neurologic disorder that can interfere with pain sensation;

• Patients with a history of drug or alcohol abuse;

• Patients who are unable to understand or follow instructions;

• Patients with an allergy or a contraindication to any of the medications used in the study, or patients with a contraindication to any of the study procedures;

• Patients with severe liver disease, renal insufficiency, congestive heart failure, and/ or significant heart disease;

• Patients with a BMI over 42;

• Any patient that the investigators feel cannot comply with all study related procedures.

• Patients who do not tolerate Percocet.